ArticleiScience2026
Large language models for predicting one-year major adverse cardiovascular events in acute coronary syndrome.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective risk stratification is crucial for managing acute coronary syndrome (ACS). This study evaluated whether general-purpose large language models (LLMs) can reliably execute the complex clinical reasoning required for cardiovascular prognosis. We quantitatively assessed three LLMs-ChatGPT 4o, DeepSeek R1, and Grok 3-for predicting one-year major adverse cardiovascular events (MACEs), using 29 guideline-recommended features from 903 participants in the LM-ACS cohort and 64 participants in the MIMIC database. All models demonstrated significant risk overestimation and substantial output variability across ten independent runs. Although Grok 3 showed the highest initial accuracy, its average performance over all runs showed no significant difference. ROC analysis indicated that none of the LLMs outperformed traditional clinical scores, with ChatGPT 4o performing below both GRACE and TIMI score. These findings demonstrate that current LLMs are not yet suitable for standalone ACS prognosis prediction; specifically, their associative reasoning poses a fundamental challenge to reliable clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.